Kistler-Tiffany Companies’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Kistler-Tiffany Companies’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,725	Closed	-$29K	–	646
2014 Q4	$29K	Hold	1,725	–	–	0.02%	316
2014 Q3	$21K	Hold	1,725	–	–	0.01%	364
2014 Q2	$10K	Hold	1,725	–	–	0.01%	440
2014 Q1	$6K	Buy	+1,725	New	+$6.57K	﹤0.01%	476

Kistler-Tiffany Companies's AVNR Position: Q1 2015 in Review

Kistler-Tiffany Companies sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,725 shares — an estimated $29K sold.

Kistler-Tiffany Companies first reported a position in AVNR in Q1 2014 and held it in 4 quarters. The position peaked at $29K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Kistler-Tiffany Companies reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Kistler-Tiffany Companies sold 1,725 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $29K.
Kistler-Tiffany Companies first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q1 2014 and held it in 4 quarters.
Kistler-Tiffany Companies's AVANIR PHARMACEUTICALS, INC CL A position peaked at $29K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Kistler-Tiffany Companies's 13F filing for Q1 2015, filed 6 May 2015.